Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer treatment utilizing SP-141 to bind with MDM2 and act as an inhibitor of MDM2 expression

Cancer treatment utilizing SP-141 to bind with MDM2 and act as an inhibitor of MDM2 expression

US Patent 10472355 · Granted Nov 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Wound dressing2025
Decoder-only transformer model for time series data2025
Substituted bisphenylalkylurea compounds and methods of treating breast cancer2025
Virus for treatment of tumor2023
Echovirus for treatment of tumors2023
Automated control of a manufacturing process2022
Modified oligonucleotides and compound that can be used for synthesizing same2022
Micro device mass transfer tool2022
Tabular data generation for machine learning model training system2022
Systematic device for abyssal sediment pressure-holding transfer2021
Liposomal lupeol acetate and the use thereof in preparing drugs for rheumatoid a2019
Enhancing processing speeds for generating a model on an electronic device2019